A One Health view of antimicrobial resistance in North Africa: Meta-analysis of ESBL-producing Enterobacteriaceae across sectors. [PDF]
Abi O +10 more
europepmc +1 more source
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians [PDF]
Corcione, Silvia +4 more
core +1 more source
Caiyun Li,1,* Fa Zhang,1,* Gang Li,2,3 Wen Wang2,3 1Department of Clinical Laboratory, Nanjing Pukou People’s Hospital, Nanjing, 211800, People’s Republic of China; 2Center of Medical Laboratory, General Hospital of Ningxia Medical University ...
Li C, Zhang F, Li G, Wang W
doaj
Cumulative cefepime exposure in cancer patients is associated with an increased risk of ertapenem non-susceptible, meropenem susceptible Enterobacterales bacteremia. [PDF]
Stabler AV +7 more
europepmc +1 more source
Multicenter Analytical Performance Evaluation of the BD Phoenix NMIC-461 Panel for Carbapenemase Classification and Antimicrobial Susceptibility Testing of <i>Enterobacterales</i>, <i>Pseudomonas aeruginosa</i>, and <i>Acinetobacter</i> spp. [PDF]
Zhang J +10 more
europepmc +1 more source
Comparison of outcomes of KPC-producing Enterobacterales bloodstream infections treated with ceftazidime-avibactam and other conventional antibiotics: retrospective single-center study. [PDF]
Kwon K +10 more
europepmc +1 more source
The bug, the burden, and the biology: beyond host-centric phenotyping in sepsis. [PDF]
Kitsios GD, Baron RM.
europepmc +1 more source
Genetically Similar High-Risk Strains of Carbapenemase-Producing Enterobacterales in Humans and Companion Animals, United States. [PDF]
Xiaoli L +9 more
europepmc +1 more source
Cefepime Combined with Late-Generation β-Lactamase Inhibitors: Mechanisms of Action, In Vitro Activity, PK/PD Characteristics, Clinical Evidence and Resistance Mechanisms. [PDF]
Comini S +3 more
europepmc +1 more source
The shift from "MIC-Only" back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance. [PDF]
Simner PJ.
europepmc +1 more source

